Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Infective Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Infective Treatmentmarket, defines the market attractiveness level of Anti-Infective Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Infective Treatment industry, describes the types of Anti-Infective Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Infective Treatment market and the development prospects and opportunities of Anti-Infective Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Infective Treatment market in Chapter 13.
By Player:
Merck
Sanofi-Aventis
Daiichi Sankyo
Obetech
Gilead Sciences
Wyeth
NanoViricides
Pfizer
Roche Pharma AG
Basilea Pharmaceutica AG
Theravance
Abbott
Optimer Pharmaceuticals
Novabay Pharmaceuticals
Bristol-Myers Squibb
Johnson
MerLion Pharma
GlaxoSmithKline
Novartis AG
Nanosphere
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Drugs Stores
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Infective Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Infective Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Infective Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Infective Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Infective Treatment Market Analysis and Outlook to 2022
-
7.1 Global Anti-Infective Treatment Consumption (2017-2022)
-
7.2 United States Anti-Infective Treatment Consumption (2017-2022)
-
7.3 Europe Anti-Infective Treatment Consumption (2017-2022)
-
7.4 China Anti-Infective Treatment Consumption (2017-2022)
-
7.5 Japan Anti-Infective Treatment Consumption (2017-2022)
-
7.6 India Anti-Infective Treatment Consumption (2017-2022)
-
7.7 South Korea Anti-Infective Treatment Consumption (2017-2022)
8 Region and Country-wise Anti-Infective Treatment Market Analysis and Outlook to 2028
-
8.1 Global Anti-Infective Treatment Consumption Forecast (2022-2028)
-
8.2 United States Anti-Infective Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Infective Treatment Consumption Forecast (2022-2028)
-
8.4 China Anti-Infective Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Infective Treatment Consumption Forecast (2022-2028)
-
8.6 India Anti-Infective Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Infective Treatment Consumption Forecast (2022-2028)
9 Global Anti-Infective Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Infective Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Infective Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-Infective Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Infective Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Infective Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Infective Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Infective Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Infective Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Infective Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Infective Treatment Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Anti-Infective Treatment Product and Service
-
14.2 Sanofi-Aventis
-
14.2.1 Sanofi-Aventis Company Details
-
14.2.2 Sanofi-Aventis Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi-Aventis Anti-Infective Treatment Product and Service
-
14.3 Daiichi Sankyo
-
14.3.1 Daiichi Sankyo Company Details
-
14.3.2 Daiichi Sankyo Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Daiichi Sankyo Anti-Infective Treatment Product and Service
-
14.4 Obetech
-
14.4.1 Obetech Company Details
-
14.4.2 Obetech Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Obetech Anti-Infective Treatment Product and Service
-
14.5 Gilead Sciences
-
14.5.1 Gilead Sciences Company Details
-
14.5.2 Gilead Sciences Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gilead Sciences Anti-Infective Treatment Product and Service
-
14.6 Wyeth
-
14.6.1 Wyeth Company Details
-
14.6.2 Wyeth Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Wyeth Anti-Infective Treatment Product and Service
-
14.7 NanoViricides
-
14.7.1 NanoViricides Company Details
-
14.7.2 NanoViricides Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 NanoViricides Anti-Infective Treatment Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Anti-Infective Treatment Product and Service
-
14.9 Roche Pharma AG
-
14.9.1 Roche Pharma AG Company Details
-
14.9.2 Roche Pharma AG Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Pharma AG Anti-Infective Treatment Product and Service
-
14.10 Basilea Pharmaceutica AG
-
14.10.1 Basilea Pharmaceutica AG Company Details
-
14.10.2 Basilea Pharmaceutica AG Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Basilea Pharmaceutica AG Anti-Infective Treatment Product and Service
-
14.11 Theravance
-
14.11.1 Theravance Company Details
-
14.11.2 Theravance Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Theravance Anti-Infective Treatment Product and Service
-
14.12 Abbott
-
14.12.1 Abbott Company Details
-
14.12.2 Abbott Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Abbott Anti-Infective Treatment Product and Service
-
14.13 Optimer Pharmaceuticals
-
14.13.1 Optimer Pharmaceuticals Company Details
-
14.13.2 Optimer Pharmaceuticals Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Optimer Pharmaceuticals Anti-Infective Treatment Product and Service
-
14.14 Novabay Pharmaceuticals
-
14.14.1 Novabay Pharmaceuticals Company Details
-
14.14.2 Novabay Pharmaceuticals Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Novabay Pharmaceuticals Anti-Infective Treatment Product and Service
-
14.15 Bristol-Myers Squibb
-
14.15.1 Bristol-Myers Squibb Company Details
-
14.15.2 Bristol-Myers Squibb Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Bristol-Myers Squibb Anti-Infective Treatment Product and Service
-
14.16 Johnson
-
14.16.1 Johnson Company Details
-
14.16.2 Johnson Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Johnson Anti-Infective Treatment Product and Service
-
14.17 MerLion Pharma
-
14.17.1 MerLion Pharma Company Details
-
14.17.2 MerLion Pharma Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 MerLion Pharma Anti-Infective Treatment Product and Service
-
14.18 GlaxoSmithKline
-
14.18.1 GlaxoSmithKline Company Details
-
14.18.2 GlaxoSmithKline Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 GlaxoSmithKline Anti-Infective Treatment Product and Service
-
14.19 Novartis AG
-
14.19.1 Novartis AG Company Details
-
14.19.2 Novartis AG Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Novartis AG Anti-Infective Treatment Product and Service
-
14.20 Nanosphere
-
14.20.1 Nanosphere Company Details
-
14.20.2 Nanosphere Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 Nanosphere Anti-Infective Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Infective Treatment
-
Figure Anti-Infective Treatment Picture
-
Table Global Anti-Infective Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Infective Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Infective Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Infective Treatment Consumption by Country (2017-2022)
-
Figure United States Anti-Infective Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Infective Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Infective Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Infective Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Infective Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Infective Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Infective Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Infective Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Infective Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Infective Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Infective Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Infective Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Infective Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Infective Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Infective Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti-Infective Treatment Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Anti-Infective Treatment Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Anti-Infective Treatment Product and Service
-
Table Obetech (Foundation Year, Company Profile and etc.)
-
Table Obetech Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Obetech Anti-Infective Treatment Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Anti-Infective Treatment Product and Service
-
Table Wyeth (Foundation Year, Company Profile and etc.)
-
Table Wyeth Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wyeth Anti-Infective Treatment Product and Service
-
Table NanoViricides (Foundation Year, Company Profile and etc.)
-
Table NanoViricides Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table NanoViricides Anti-Infective Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-Infective Treatment Product and Service
-
Table Roche Pharma AG (Foundation Year, Company Profile and etc.)
-
Table Roche Pharma AG Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Pharma AG Anti-Infective Treatment Product and Service
-
Table Basilea Pharmaceutica AG (Foundation Year, Company Profile and etc.)
-
Table Basilea Pharmaceutica AG Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Basilea Pharmaceutica AG Anti-Infective Treatment Product and Service
-
Table Theravance (Foundation Year, Company Profile and etc.)
-
Table Theravance Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Anti-Infective Treatment Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Anti-Infective Treatment Product and Service
-
Table Optimer Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Optimer Pharmaceuticals Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Optimer Pharmaceuticals Anti-Infective Treatment Product and Service
-
Table Novabay Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Novabay Pharmaceuticals Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novabay Pharmaceuticals Anti-Infective Treatment Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Anti-Infective Treatment Product and Service
-
Table Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson Anti-Infective Treatment Product and Service
-
Table MerLion Pharma (Foundation Year, Company Profile and etc.)
-
Table MerLion Pharma Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table MerLion Pharma Anti-Infective Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti-Infective Treatment Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Anti-Infective Treatment Product and Service
-
Table Nanosphere (Foundation Year, Company Profile and etc.)
-
Table Nanosphere Anti-Infective Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanosphere Anti-Infective Treatment Product and Service
-
